Search research articles
Contact Us
Filters
Showing results (241-250 of 292) with videos related to
Page
of 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
Toni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Oncoimmunology
|
November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection
Daniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.
Cancer Discovery
|
January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Hubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
Nature Cancer
|
February 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Evanthia T Roussos Torres, Won J Ho, Ludmila Danilova, et al.
Cancer Immunology Research
|
June 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors
Howard L Li, Soren Charmsaz, Chester Kao, et al.
Molecular Cancer Therapeutics
|
October 9, 2021
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer
Spas Dimitrov Markov, Thomas C Caffrey, Kelly A O'Connell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2009
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer
Amanda Blackford, Oscar K Serrano, Christopher L Wolfgang, et al.
Journal of Hepatology
|
November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
Zeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer
Eric S Christenson, Won Jin Ho, Daniel Shu, et al.
The Journal of Pathology
|
July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Wei Zhou, Adrian M Jubb, Karen Lyle, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 292) with videos related to
Sort By:
Page
of 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response
Toni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Oncoimmunology
|
November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection
Daniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.
Cancer Discovery
|
January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Hubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
Nature Cancer
|
February 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Evanthia T Roussos Torres, Won J Ho, Ludmila Danilova, et al.
Cancer Immunology Research
|
June 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors
Howard L Li, Soren Charmsaz, Chester Kao, et al.
Molecular Cancer Therapeutics
|
October 9, 2021
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer
Spas Dimitrov Markov, Thomas C Caffrey, Kelly A O'Connell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2009
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer
Amanda Blackford, Oscar K Serrano, Christopher L Wolfgang, et al.
Journal of Hepatology
|
November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC
Zeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer
Eric S Christenson, Won Jin Ho, Daniel Shu, et al.
The Journal of Pathology
|
July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Wei Zhou, Adrian M Jubb, Karen Lyle, et al.
Page
of 30